LIFESTANCE HEALTH ($LFST) posted quarterly earnings results for Q1 2026 on Thursday, May 7th. The company reported earnings of $0.04 per share, beating estimates of $0.01 by $0.03. The company also reported revenue of $403,480,000, beating estimates of $395,114,217 by $8,365,783.
You can see Quiver Quantitative's $LFST stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LIFESTANCE HEALTH Insider Trading Activity
LIFESTANCE HEALTH insiders have traded $LFST stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $LFST stock by insiders over the last 6 months:
- GP A, LLC TPG sold 20,685,061 shares for an estimated $145,002,277
- ROBERT BESSLER has made 0 purchases and 16 sales selling 295,086 shares for an estimated $2,074,422.
- LISA K MILLER (See Remarks) sold 57,240 shares for an estimated $368,053
- ANN VARANAKIS (Chief People Officer) sold 50,000 shares for an estimated $345,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
LIFESTANCE HEALTH Hedge Fund Activity
We have seen 122 institutional investors add shares of LIFESTANCE HEALTH stock to their portfolio, and 91 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 13,055,317 shares (-68.1%) from their portfolio in Q4 2025, for an estimated $91,909,431
- FMR LLC added 7,840,028 shares (+20.1%) to their portfolio in Q4 2025, for an estimated $55,193,797
- AUSTRALIANSUPER PTY LTD removed 3,101,010 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $21,831,110
- VANGUARD GROUP INC added 3,086,506 shares (+21.1%) to their portfolio in Q4 2025, for an estimated $21,729,002
- BROWN ADVISORY INC removed 2,997,842 shares (-88.5%) from their portfolio in Q4 2025, for an estimated $21,104,807
- JENNISON ASSOCIATES LLC added 2,843,388 shares (+38.5%) to their portfolio in Q1 2026, for an estimated $18,112,381
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 1,703,725 shares (-79.3%) from their portfolio in Q4 2025, for an estimated $11,994,224
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
LIFESTANCE HEALTH Analyst Ratings
Wall Street analysts have issued reports on $LFST in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BMO Capital issued a "Outperform" rating on 11/13/2025
To track analyst ratings and price targets for LIFESTANCE HEALTH, check out Quiver Quantitative's $LFST forecast page.
LIFESTANCE HEALTH Price Targets
Multiple analysts have issued price targets for $LFST recently. We have seen 6 analysts offer price targets for $LFST in the last 6 months, with a median target of $9.5.
Here are some recent targets:
- Peter Warendorf from Barclays set a target price of $9.0 on 03/06/2026
- Scott Schoenhaus from Keybanc set a target price of $9.0 on 02/26/2026
- Richard Close from Canaccord Genuity set a target price of $10.0 on 02/26/2026
- Kevin Caliendo from UBS set a target price of $12.0 on 02/26/2026
- David Larsen from BTIG set a target price of $11.0 on 02/02/2026
- Sean Dodge from BMO Capital set a target price of $8.0 on 11/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
